Subscribe To
PRCT / PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on May 11, 2022
Content Topics
Procept
Biorobotics
Corp
Report
First
Quarter
2022
Financial
Results
Attend
America
Healthcare
Conference
Stock
PRCT
PRCT News
By Seeking Alpha
November 2, 2023
PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript
PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript more_horizontal
By Seeking Alpha
August 10, 2023
Procept BioRobotics: Adding Value Through Robust Unit Economics, Reiterate Buy
PRCT's aquablation therapy has shown strong growth, with revenues of $57.5mm in Q2 FY'23. The company's economic levers include new system placements, more_horizontal
By Zacks Investment Research
July 27, 2023
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.57. This more_horizontal
By GlobeNewsWire
July 11, 2023
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
REDWOOD CITY, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics comp more_horizontal
By Seeking Alpha
May 30, 2023
Procept BioRobotics: Adding For 2023 Rebound
Procept had weak results on adding fewer than expected Aquabeam devices in Q1 of 2023, leading to a fall in the shares. Procept has strong potential i more_horizontal
By Seeking Alpha
April 30, 2023
PROCEPT BioRobotics Corporation (PRCT) Q1 2023 Earnings Call Transcript
Start Time: 08:00 January 1, 0000 8:56 AM ET PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q1 2023 Earnings Conference Call April 27, 2023, 08:00 AM more_horizontal
By Zacks Investment Research
April 27, 2023
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.59. This more_horizontal
By GlobeNewsWire
April 5, 2023
PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas
REDWOOD CITY, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics com more_horizontal